Movement disorders and neuropathies: overlaps and mimics in clinical practice

被引:0
作者
Francesco Gentile
Alessandro Bertini
Alberto Priori
Tommaso Bocci
机构
[1] University of Milan,Clinical Neurology Unit, “Azienda Socio
[2] University of Milan,Sanitaria Territoriale Santi Paolo E Carlo” and Department of Health Sciences
来源
Journal of Neurology | 2022年 / 269卷
关键词
Movement disorders; Peripheral neuropathy; Parkinsonisms; a-Synuclein; Inflammatory; Paraneoplastic; Genetics;
D O I
暂无
中图分类号
学科分类号
摘要
Movement disorders as well as peripheral neuropathies are extremely frequent in the general population; therefore, it is not uncommon to encounter patients with both these conditions. Often, the coexistence is coincidental, due to the high incidence of common causes of peripheral neuropathy, such as diabetes and other age-related disorders, as well as of Parkinson disease (PD), which has a typical late onset. Nonetheless, there is broad evidence that PD patients may commonly develop a sensory and/or autonomic polyneuropathy, triggered by intrinsic and/or extrinsic mechanisms. Similarly, some peripheral neuropathies may develop some movement disorders in the long run, such as tremor, and rarely dystonia and myoclonus, suggesting that central mechanisms may ensue in the pathogenesis of these diseases. Although rare, several acquired or hereditary causes may be responsible for the combination of movement and peripheral nerve disorders as a unique entity, some of which are potentially treatable, including paraneoplastic, autoimmune and nutritional aetiologies. Finally, genetic causes should be pursued in case of positive family history, young onset or multisystemic involvement, and examined for neuroacanthocytosis, spinocerebellar ataxias, mitochondrial disorders and less common causes of adult-onset cerebellar ataxias and spastic paraparesis. Deep phenotyping in terms of neurological and general examination, as well as laboratory tests, neuroimaging, neurophysiology, and next-generation genetic analysis, may guide the clinician toward the correct diagnosis and management.
引用
收藏
页码:4646 / 4662
页数:16
相关论文
共 1193 条
  • [1] Reimann J(2017)Movement disorders hidden in the neuromuscular clinic Neuromuscul Disord 27 S243-269
  • [2] Paus S(2016)The wrong end of the telescope: neuromuscular mimics of movement disorders (and vice versa) Pract Neurol 16 264-209
  • [3] Bloem BR(2017)Peripheral neuropathy in idiopathic Parkinson's disease: a systematic review J Neurol Sci 378 204-50
  • [4] Voermans NC(2018)Peripheral neuropathy is associated with more frequent falls in Parkinson's disease Parkinsonism Relat Disord 54 46-1397
  • [5] Aerts MB(2013)Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study Mov Disord 28 1391-36
  • [6] Bhatia KP(2010)Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease Ann Neurol 68 28-1950
  • [7] van Engelen BG(2011)Neuropathy in Parkinson disease: prevalence and determinants Neurology 77 1947-2701
  • [8] van de Warrenburg BP(2020)Peripheral neuropathy in Parkinson's disease Neurol Sci 41 2691-72
  • [9] Zis P(2005)Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients Mov Disord 20 69-127
  • [10] Grunewald RA(2014)Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment Parkinsonism Relat Disord 20 125-2294